Pharmaids Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 0.17 | 0.04 | -0.88 |
| Operating Expense | 1.88 | 1.81 | 1.32 |
| Net Profit | -1.62 | -2.24 | -1.63 |
| Net Profit Margin | -952.94 | -5,600.00 | 185.23 |
| Earning Per Share | -0.46 | -0.98 | -0.76 |
| EBIDTA | -1.56 | -1.90 | -1.62 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 0.17 |
| Operating Expense | 1.88 |
| Net Profit | -1.62 |
| Net Profit Margin | -952.94 |
| Earning Per Share | -0.46 |
| EBIDTA | -1.56 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 0.03 | TBA | 3.94 |
| Operating Expenses Annual | 6.40 | 9.89 | 3.80 |
| Operating Profit Annual | -5.58 | -9.89 | 0.15 |
| Interest Annual | 0.33 | TBA | 0.00 |
| Depreciation | 0.18 | 0.02 | 0.01 |
| Net Profit Annual | -4.95 | -7.56 | 0.15 |
| Tax Annual | -1.14 | -2.35 | -0.00 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 0.03 |
| Operating Expenses Annual | 6.40 |
| Operating Profit Annual | -5.58 |
| Interest Annual | 0.33 |
| Depreciation | 0.18 |
| Net Profit Annual | -4.95 |
| Tax Annual | -1.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 12.75 | 0.41 | 0.20 |
| Cash Flow from Operations | -3.44 | -4.02 | -0.26 |
| Cash Flow from Investing | -72.51 | -4.95 | 0.47 |
| Cash Flow from Financing | 65.66 | 21.31 | TBA |
| Cash Flow at the End | 2.46 | 12.75 | 0.41 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 12.75 |
| Cash Flow from Operations | -3.44 |
| Cash Flow from Investing | -72.51 |
| Cash Flow from Financing | 65.66 |
| Cash Flow at the End | 2.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -18,600 | TBA | 3.81 |
| PBIT Margin (%) | -19,200 | TBA | 3.55 |
| PBT Margin (%) | 38,966.67 | TBA | 3.55 |
| Net PROFIT Margin (%) | -16,500 | TBA | 3.81 |
| Return On Networth / Equity (%) | TBA | TBA | 1.36 |
| Return On Networth /Employed (%) | TBA | TBA | 1.36 |
| Return On Assets (%) | TBA | TBA | 1.75 |
| Total Debt / Equity (X) | 0.14 | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | 0.46 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -18,600 |
| PBIT Margin (%) | -19,200 |
| PBT Margin (%) | 38,966.67 |
| Net PROFIT Margin (%) | -16,500 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | 0.14 |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 16.55 | 0.11 | 0.03 |
| Total Current Assets Annual | 4.76 | 18.28 | 2.67 |
| Non Current Assets Annual | 80.24 | 6.27 | 8.44 |
| Total Shareholders Funds Annual | 71.06 | 22.43 | 8.67 |
| Total Assets Annual | 85.00 | 24.55 | 11.11 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 16.55 |
| Total Current Assets Annual | 4.76 |
| Non Current Assets Annual | 80.24 |
| Total Shareholders Funds Annual | 71.06 |
| Total Assets Annual | 85.00 |
EPS (INR)
Expected
0.00
Reported
-0.76
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.00%
